T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $83.7M | 0.01% |
3,754,870
+1,574,910
| +72% | +$32.5M |
|
677
Helios Technologies
HLIO
$2.67B
| $83M | 0.01% |
1,537,750
-405,745
| -21% | -$18.8M |
|
678
DaVita
DVA
$11.4B
| $82.8M | 0.01% |
1,394,320
-833,989
| -37% | -$50.2M |
|
679
TherapeuticsMD
TXMD
$24.1M
| $82.7M | 0.01% |
312,780
-87,723
| -22% | -$25.4M |
|
680
Cognex
CGNX
$10.4B
| $82.5M | 0.01% |
1,496,126
-2,408,310
| -62% | -$122M |
|
|
TRVG
681
trivago
TRVG
$365M
| $82.4M | 0.01% |
1,518,351
+704,224
| +87% | +$59.3M |
|
682
Cummins
CMI
$87B
| $82.3M | 0.01% |
489,888
-1,913,602
| -80% | -$310M |
|
|
IPCC
683
DELISTED
Infinity Property & Casualty C
IPCC
| $82.1M | 0.01% |
871,862
-7,093
| -0.8% | -$658K |
|
684
WSFS Financial
WSFS
$4.17B
| $82M | 0.01% |
1,682,091
+750,425
| +81% | +$33.9M |
|
685
Hilton Grand Vacations
HGV
$3.49B
| $81.8M | 0.01% |
2,118,319
-656,677
| -24% | -$23.8M |
|
686
First American
FAF
$7.56B
| $81.7M | 0.01% |
1,634,106
-34,986
| -2% | -$1.67M |
|
|
GCP
687
DELISTED
GCP Applied Technologies Inc.
GCP
| $81.6M | 0.01% |
2,657,057
+1,652,085
| +164% | +$49.4M |
|
688
Prudential Financial
PRU
$43B
| $81.3M | 0.01% |
764,506
-28,916
| -4% | -$3.09M |
|
689
Dime Commercial Bancshares
DCOM
$1.82B
| $81.2M | 0.01% |
2,391,742
+113,512
| +5% | +$3.64M |
|
690
Avient
AVNT
$4.23B
| $80.4M | 0.01% |
2,008,153
-437,199
| -18% | -$16.3M |
|
691
Preferred Bank
PFBC
$1.28B
| $80.3M | 0.01% |
1,330,142
-39,097
| -3% | -$2.15M |
|
|
LNCE
692
DELISTED
Snyders-Lance, Inc.
LNCE
| $80.3M | 0.01% |
2,104,175
+101,180
| +5% | +$3.65M |
|
693
Take-Two Interactive
TTWO
$45.2B
| $80M | 0.01% |
782,607
+27,206
| +4% | +$2.44M |
|
694
Truist Financial
TFC
$64.7B
| $79.7M | 0.01% |
1,698,290
-69,572
| -4% | -$3.2M |
|
|
WPX
695
DELISTED
WPX Energy, Inc.
WPX
| $79.6M | 0.01% |
6,922,443
+747,890
| +12% | +$7.65M |
|
696
Deere & Co
DE
$165B
| $79M | 0.01% |
629,137
+31,979
| +5% | +$3.94M |
|
697
Theravance Biopharma
TBPH
$878M
| $78.8M | 0.01% |
2,300,296
+980,855
| +74% | +$32.1M |
|
|
CA
698
DELISTED
CA, Inc.
CA
| $78.7M | 0.01% |
2,357,907
-23,107
| -1% | -$764K |
|
699
Cognizant
CTSH
$26.7B
| $78.6M | 0.01% |
1,083,945
-1,327,284
| -55% | -$93.2M |
|
700
Acadia Pharmaceuticals
ACAD
$4.89B
| $78.6M | 0.01% |
2,086,597
-1,372,667
| -40% | -$44.7M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.